For the first time, scientists have discovered that cells passed from mother to child during pregnancy can differentiate into functioning islet beta cells that produce insulin in the child.
Changing to a healthier lifestyle appears to be at least as effective as taking prescription drugs in reducing the risk of developing Type 2 diabetes, says a new BMJ study. Type 2 diabetes is a growing problem — in England around 1.3 million people have diabetes and around five percent of total NHS resources are used for the care of people with diabetes.
Modern blood-pressure treatments are less likely to be associated with new cases of diabetes than older medicines — William Elliott of Rush University Medical Center, Chicago, and colleagues reported in the Lancet medical journal.
Changing to a healthier lifestyle appears to be at least as effective as taking prescription drugs in reducing the risk of developing Type 2 diabetes, says a new BMJ study. Type 2 diabetes is a growing problem ? in England around 1.3 million people have diabetes and around 5% of total NHS resources are used for the care of people with diabetes.
The Honourable Tony Clement, Minister of Health, today announced that Health Canada is developing an innovative pilot project in partnership with Saint Elizabeth Health Care and the Assembly of Manitoba Chiefs, to establish a wait times guarantee for First Nations people living on reserve in Manitoba who face debilitating infections and possible amputations arising from diabetes.
Researchers at Wake Forest University School of Medicine are the first to report that in animal studies, a common diabetes drug prevents the memory and learning problems that cancer patients often experience after whole-brain radiation treatments.
University of Pittsburgh investigators have successfully prevented the onset of type 1 diabetes in mice prone to developing the disease using an antibody against a receptor on the surface of immune T-cells. According to the investigators, these findings, which are being published in the January issue of the journal Diabetes, have significant implications for the prevention of type 1 diabetes.
Nutrition 21, Inc., today announced the results of a recent placebo controlled, double-blind, randomized, single center study that demonstrated that Diachrome, a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.
A new study on risk factors of new-onset diabetes mellitus (NODM) following liver transplant found that a history of obesity, impaired fasting glucose and hepatitis C infection (HCV) paired with the use of a particular immunosuppressant are associated with an increased risk of NODM. Since all of these factors can be detected prior to undergoing a transplant, treatment should be tailored to the patient’s risk.
Many individuals with type 2 diabetes are diabetic because the cells of their body no longer respond to the hormone insulin, which is crucial for lowering blood sugar levels (blood glucose levels). However, before individuals become clinically diabetic their body tries to compensate for the increasing resistance to the effects of insulin by increasing both the amount of insulin secreted and the mass of insulin-secreting cells (beta cells) in the pancreas.